The Latest Breaking News from MMM

3M has outperformed the broader market over the past year, and Wall Street analysts are moderately bullish about the stock’s prospects.

3M Company's stock has surged 38% year-to-date, raising questions about whether the Dow component is overbought - but the company's solid earnings outlook, strategic investments, and dividend adjustments suggest it may still have hidden value and potential for future growth.

3M Company has lagged behind the broader market over the past year, and analysts remain cautious about the stock's potential.

Dividend aristocracy isn't always a sure thing. Here are 3 companies that have been or will be booted from the coveted king's list.

3M stock is a Dividend King no more, as the company slashed its payout following the Solventum spinoff. Is the stock still a buy for investors seeking passive income?

3M is snapping its decades-long streak of dividend hikes, yet it's been one of the best Dow Jones stocks this week. Here's what you need to know.

In this article, discover 3 three companies with eye-watering yields and have raised their dividend for 50+ years.

Barclays' recent upgrade of 3M's stock to Overweight, coupled with a new CEO at the helm and a promising spin-off of its healthcare segment, suggests that this Dividend King may be an undervalued investment with significant upside potential.

MMM to help Chad set up healthcare facilities; training of personnel, telemedicine services to be provided. Raju George, CEO of MMM, and Mahamat Hissein Ali, Deputy Medical Director of Hospitalier Universitaire La Renaissance, agree to collaborate. MMM to provide training, telemedicine services, and help set up pathology, nephrology, cardiology, rheumatology,…